yahoo.com
Jul 24, 2008
Thursday July 24, 8:00 am ET Company Will Hold Conference Call at 9:00 a.m. ET ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX - News ), a leading processor of orthopedic and other biologic implants, reported operating results for the quarter ended June 30, 2008 as follows: Second Quarter Highlights: Increased gross margin to 48 percent for the quarter compared to 38 percent in prior year and 46 percent in the first quarter 2008 Commenced shipments of fresh osteochondral grafts, which is exceeding expectations Shipped launch quantities of two new spinal implants and one bone graft substitute implant Received FDA clearance for bovine pericardium membrane for dental applications Received FDA clearance for Tutomesh® xenograft implant and updated claims for Tutopatch® implant for hernia repair applications...
[read full story]